Dear Chair Guthrie and Ranking Member Pallone,
As groups representing people living with diabetes and health professionals, we are writing to express our continued concern that Centers for Medicare & Medicaid Services (CMS) applying the competitive bidding program (CBP) to continuous glucose monitors (CGMs) and insulin pumps will leave Medicare beneficiaries without access to these critical, lifesaving diabetes technologies. We urge you to pass legislation that blocks or delays implementation of the CBP for CGMs and insulin pumps until CMS can ensure patient access to these technologies will not be disrupted and Medicare beneficiaries’ health will not be put at risk.
